You are here: » People » Researcher » Martin, Keith

Keith Martin

Short CV

Keith Martin qualified from Oxford University Clinical School in 1993 and trained in general medicine and neurology at Hamersmith Hospital and the National Hospital for Neurology & Neurosurgery in London and the John Radcliffe Hospital in Oxford.

His Higher Specialist Training in Ophthalmology was undertaken at Addenbrooke's Hospital in Cambridge . He completed three years of post-doctoral research on the pathogenesis of retinal ganglion cell death glaucoma at the Wilmer Eye Institute, Johns Hopkins University, Baltimore, USA and at the Institute of Ophthalmology in London.

He was awarded a Doctor of Medicine degree by Oxford University in 2004 and a GSK Clinician-Scientist Fellowship in 2005.

Clinically, he specialises in the medical and surgical management of adult and paediatric glaucoma patients with a particular interest in advanced, complex and uveitic disease. Current research work is focused on the mechanisms of visual loss in glaucoma and the development of new treatment approaches.

Scientifc Interest

The mechanisms of visual loss in glaucoma and the development of new treatment approaches.


  • World Glaucoma Association (Associate Board Member, 2005 -)
  • Royal College of Ophthalmologists
  • Royal College of Physicians
  • Association for Research in Vision and Ophthalmology
  • American Academy of Ophthalmology
  • British Eye Study Group
  • UK and Ireland Glaucoma Society
Keith Martin
Keith Martin

Research Group

Glaucoma Research Group


Cambridge University

Centre for Brain Repair
Forvie Site
Robinson Way
United Kingdom

Phone: +44-1223-331160
Fax: +44-1223-217968



Key Publications

  1. Beirowski B, Babetto E, Coleman MP, Martin KR.
    The Wlds gene delays axonal but not somatic degeneration in a rat glaucoma model.
    Eur J Neurosci 2008;28:1166–1179.
  2. Bull ND, Johnson TV, Martin KR.
    Stem cells for neuroprotection in glaucoma.
    Prog Brain Res. 2008;173:511-9.
  3. Bull ND and Martin KR.
    Human Müller stem cell (MIO-M1) transplantation in a rat model of glaucoma: survival, differentiation and integration.
    Invest Ophthalmol Vis Sci. 2008;49(8):3449-56
  4. Johnson TV and Martin KR.
    Development and characterization of an adult retinal explant organotypic tissue culture system as an in vitro intraocular stem cell transplantation model.
    Invest Ophthalmol Vis Sci 2008;49(8):3503-12
  5. Bull ND and Martin KR.
    Optic nerve restoration: new perspectives.
    J Glaucoma 2007 16(5):506-11.
  6. Martin KR, Quigley HA, Valenta DF, Kielczewski J, Pease ME.
    Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma.
    Exp Eye Res 2006;83(2):255-62.
  7. Martin KR, Levkovitch-Verbin H, Valenta D, Baumrind LA, Pease ME, Quigley HA.
    Retinal glutamate transporter changes in experimental glaucoma and following optic nerve transection in the rat.
    Invest Ophthalmol Vis Sci 2002;43(7):2236-43.
  8. Martin KR and Quigley HA.
    Gene therapy for optic nerve diseases.
    Eye 2004;18:1049-1055.
  9. Martin KR, Quigley HA, Zack DJ, Klein RL, Levkovitch-Verbin H, Valenta D, Baumrind LA, Pease ME, Hauswirth WW.
    Gene therapy with brain derived neurotrophic factor as a protection for retinal ganglion cells in a rat glaucoma model.
    Invest Ophthalmol Vis Sci 2003;43:2236-2243
  10. Levkovitch-Verbin H, Quigley HA, Martin KR, Zack D, Pease ME, Valenta D
    A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection.
    Invest Ophthalmol Vis Sci 2003;44(8):3388-93

Research Groups